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Case Report: General Anesthetic Management for Laparoscopic 
Cholecystectomy in Paramyotonia Congenita  
Analise McGreal,1 Daniel Slagle,1 Andrew Dickens.2 
Abstract 
Background: Paramyotonia congenita (PC) is a rare disorder affecting skeletal muscle. Patients with this non-progressive condition experience intermittent 
episodes of sustained myotonia. Due to the predisposition for prolonged muscle contraction, special attention must be given to anesthetic management 
during operative procedures to prevent complications similar to those experienced in patients with malignant hyperthermia. To date, however, limited 
reports of anesthetic management in paramyotonia congenita are available. The Case: The present report describes successful general anesthetic 
management given to a patient with paramyotonia congenita using propofol and ketamine for induction, non-depolarizing rocuronium for muscle paralysis, 
and continuous nitrous oxide and IV propofol infusion for sedation. The patient remained stable throughout the case without myotonic episodes or other 
complications. Conclusion: Our report describes successful anesthetic management in a patient with paramyotonia congenita. This provides a potential 
management plan that may be applied to PC patients undergoing a variety of surgical procedures and eliminates risk associated with succinylcholine and 
possibly volatile anesthetics. Further research is needed to determine whether this approach is superior to previously reported techniques and should 
also identify which agents may be effectively utilized to reverse an intra-operative myotonic episode in PC. 
 





Paramyotonia congenita (PC) is a rare muscular disorder with an 
estimated prevalence between 1/100,000 to 1/200,000.1 The disorder is 
characterized by periodic muscle contraction, or myotonia, followed by 
flaccid paralysis.1 It is caused by an autosomal-dominant mutation in 
the SCN4A gene, which is normally responsible for regulating the 
amount of sodium and potassium ions present across the skeletal 
muscle cell membrane. Therefore, the mutation in this gene is thought 
to interfere directly with normal muscle contraction and relaxation.1 
Most patients with PC experience periodic myotonic contraction and 
paralysis by adolescence. However, in contrast to some other muscular 
disorders, PC is non-progressive and patients are expected to have a 
normal life expectancy.1 Many patients with PC do not require 
pharmacologic intervention and treatment is primarily symptomatic. 
For example, symptomatic treatment may include reduction of cold 
exposure, which may act as a trigger for myotonic episodes.1 Patients 
who do receive pharmacologic treatment may be treated with 
mexiletine for muscle relaxation.1 
 
Patients with PC experience a broad range of symptom severity. They 
are at increased risk when undergoing general anesthetic management, 
especially with succinylcholine (Figure 1).1-2 While this is similar to the 
better-known presentation of malignant hyperthermia (MH), it is 
important to note that patients with PC are not at an increased risk for 
malignant hyperthermia.3 
 
MH is usually triggered by succinylcholine and/or halogenated volatile 
anesthetics and presents with hypercarbia, muscle rigidity, 
hyperthermia, and rhabdomyolysis following anesthetic  induction.3 In 
patients with PC, the only symptom is myotonia, typically in the hands, 
face, or neck.4 Nevertheless, there is clear risk for patients with PC who 
 
undergo anesthesia.1-2 Despite the known risk associated with the use 
of common agents such as succinylcholine and some volatile 
anesthetics for general anesthesia in patients with PC, there are few 
reports of anesthetic management for this condition. Previously 
reported techniques included intubation without neuromuscular 
relaxant for pyloromyotomy and continuous IV anesthesia with 
intercostal nerve block for repair of congenital nasal dysplasia using 
autologous costal cartilage.5-6  
 
Successful anesthetic induction has been reported in patients with 
myotonic dystrophy (a similar disorder), using rocuronium, a non-
depolarizing muscle relaxant. To the authors knowledge, there are no 
reports of anesthetic management using rocuronium for paralysis in 
patients with PC.7 Thus, the present report describes successful 
management of anesthesia in a patient undergoing laparoscopic 
cholecystectomy, a common surgical procedure, using non-depolarizing 
rocuronium for muscle paralysis, propofol and ketamine for induction, 
and propofol infusion/nitrous oxide for general anesthesia 
Highlights:  
 In this case report, we describe general anesthetic induction and 
management for a patient with paramyotonia congenita, a rare 
disorder affecting skeletal muscle.  
 
 Special attention must be paid to anesthetic management during 
operative procedures to prevent complications similar to those seen 
in patients with malignant hyperthermia. 
 
 Our report provides a potential management plan that may be applied 
to PC patients undergoing a variety of surgical procedures and 
eliminates risk associated with succinylcholine and volatile anesthetics. 
Case Report  
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maintenance. Written consent and Health Insurance Portability and 
Accountability Act (HIPAA) authorization were obtained from the patient. 
 
The Case 
A 36-year-old Caucasian female presented to the outpatient general 
surgery office with complaints of several months of recurrent 
postprandial nausea. Upper endoscopy did not reveal an obvious 
etiology for nausea.  Subsequent diagnostic testing, including 
cholescintigraphy scan, was pursued and revealed a reduced 
gallbladder ejection fraction, diagnostic for biliary dyskinesia. Thus, it 
was recommended that the patient undergo elective laparoscopic 
cholecystectomy for symptomatic relief. The patient underwent pre- 
and peri-operative anesthesia exam, which revealed a past medical 
history of PC, chronic cholecystitis, gastroesophageal reflux disease 
(GERD), hypertension, asthma, hypothyroidism, and anxiety. The 
patient had not previously undergone general anesthesia, though she 
was aware of the risk associated with anesthesia due to her PC. 
 
Current medications at the time of surgery included mexiletine (150 mg 
every 12 hours), omeprazole (40 mg each day [qd]), montelukast (10 
mg every night at bed time [qhs]), azelastine hydrochloride-fluticasone 
propionate (137 mcg-50 mcg nasal spray twice a day [bid]), 
levothyroxine (50 mcg once a day [qd]), clonazepam (0.5 mg qhs), 
eszopiclone (3 mg as needed [prn]), and propranolol (10 mg prn). 
Cardiovascular and respiratory review of systems revealed no 
significant findings, aside from history of asthma as stated (mexiletine 
used for chronic pain and muscle relaxation) and the patient took 
nothing by mouth for over 8 hours. She had not used propranolol (for 
anxiety) prior to surgery.  
 
Airway exam revealed Mallampati score of 1, thyromental distance > 3 
fingerbreadths, and mouth opening > 3 fingerbreadths. Cardio-
respiratory exam revealed a regular rate and rhythm, no murmurs, 
rubs, or gallops, and non-labored respirations. Pre-operative labs 
including complete blood count (CBC) and electrolytes were within the 
normal limits and pregnancy test was negative. Vital signs prior to 
anesthetic induction included temperature of 37°C, heart rate of 96 
beats per minute, respiratory rate of 18 breaths per minute, blood 
pressure of 112/65 mmHg, and oxygen saturation of 100% on a 2L nasal 
cannula. To maintain normothermia, the patient was covered with 
heated blankets in the preoperative area and in the operating room.  A 
Bair Hugger system was also utilized throughout the duration of the 
case. 
 
Core temperature monitoring was established via the esophagus and 
recorded periodically. Normal sinus rhythm was confirmed with 
electrocardiogram (EKG). Anesthetic management began with 100 mcg 
of fentanyl, 4 mg of odansetron, and 2 mg of midazolam for pain, 
nausea, and anxiety. Antibiotic prophylaxis with 900 mg of clindamycin 
was given. Next, 200 mg of propofol and 20 mg of ketamine were used 
for induction. Rocuronium (35 mg) was given for non-depolarizing 
muscle paralysis. The trachea was smoothly intubated by video 
laryngoscope. This was performed by a registered nurse anesthetist 
under the supervision of an attending anesthesiologist. Nitrous oxide 
and continuous propofol infusion (10 mg/mL IV emulsion 100 mL at 7.59 
mg/hr) were used for maintenance of general anesthesia for the 
remainder of the case. 
 
Pre-operative and post-operative electrolytes were within normal limits. 
Intraoperative EKG monitoring was performed throughout the entire 
procedure and the patient maintained normal sinus rhythm. No 
indication of hyperkalemia (such as peaked T waves, flattening of P 
waves, or prolongation of the PR interval) was apparent for the entirety 
of EKG monitoring. Thirty minutes after anesthetic initiation, an 
additional 50-mcg fentanyl and 20 mg ketamine was given for pain 
management and sedation. Dexamethasone 4 mg and glycopyrrolate 
0.6 mg were given just prior to the completion of anesthesia (Table 1). 
The patient’s vitals remained  stable  throughout  the  case,  with  an  
Table 1. Medications Used for Anesthetic Management. 
 
Procedure Drug and dose/Procedure 
Antibiotic Prophylaxis 900 mg clindamycin 
Induction 200 mg propofol, 20 mg ketamine 
Paralytic  (Non-Depolarizing) 35 mg rocuronium 
Anesthetic Maintenance Nitrous oxide via nasal cannula, continuous propofol 
10 mg/mL IV emulsion 100 mL @ 7.5 mg/hr 
Intraoperative Monitoring 
Potassium checks; electrocardiogram 
monitoring; temperature via esophagus 
End of Sedation 4 mg dexamethasone, 0.6 mg glycopyrrolate 
 
increase in systolic blood pressure prompting further pain management 
at 30 minutes. Total anesthetic time was 85 minutes. The patient awoke 
from anesthesia without complications and was discharged home on 
the same day, approximately 2 hours after the case concluded. She was 
seen for follow up in the general surgery office one week later. She 
reported some mental fatigue following surgery and did experience a 




The present case describes successful general anesthetic management 
in a patient with PC using propofol and ketamine for induction andnon-
depolarizing rocuronium for muscle paralysis, with continuous nitrous 
oxide and IV propofol infusion for anesthesia maintenance. The patient 
remained stable throughout the case without myotonic episodes, 
evidence of hyperkalemia, or other complications. Given the clear 
contraindication to succinylcholine, this suggests that the use of non-
depolarizing agents during intubation is a viable alternative strategy in 
patients with PC when general anesthesia is required. Moreover, it is 
known that use of volatile anesthetics for maintenance anesthesia 
poses a risk for volatile anesthetics for maintenance anesthesia poses 
a risk for patients with malignant hyperthermia. There are minimal 
reports regarding the use of volatile anesthetics in patients with PC, so, 
we opted to not use sevoflurane for maintenance in our patient to avoid 
unnecessary risk. 
 
Regardless of anesthetic strategy used, hypothermia and hyperkalemia 
are the two biggest perioperative risks for a myotonic episode and 
should be monitored accordingly with a temperature probe, EKG, and 
electrolyte panels. Unfortunately, there is little evidence available to 
date regarding agents that could potentially reverse an acute myotonic 
episode, should one occur. There is only one reported case study in the 
literature that describes an acute reversal of a myotonic episode in PC 
during surgery.8 The patient was a 40-year-old female who did not know 
that she had PC and was given succinylcholine during induction.  
Immediately, she was noted to have rigidity of her upper extremities, 
neck, and masseter muscles to the extent that her mouth could not be 
opened for intubation. Mask ventilation was performed and a 100 mg 
IV propofol bolus was given and within 4-5 minutes her myotonia 
receded allowing for intubation. The surgery was then performed 
without complications. 
 
Additional research has suggested that the successful reversal may be 
secondary to the ability of propofol to block not only wild-type sodium 
channels, but also mutant sodium channels in a patient with PC.9 
Moreover, Matsumoto et al., reported a case that suggested the class 
1B anti-arrhythmic drug mexiletine could potentially be used as a 
reversal agent due to its sodium channel inhibition.7 If considered from 
a purely mechanistic view, this is logical since PC is caused by a 
derangement in sodium deactivation and mexiletine blocks sodium 
channels. However, the cited randomized control trial is somewhat 
limited because it reports that mexiletine is superior to placebo in 
reducing stiffness symptoms over a four-week period, not reversing an 
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taking mexiletine at the time of surgery for chronic pain and muscle 
rigidity. Although it is unclear if this lowered her risk of myotonia intra-
operatively, this could represent an important limitation of the present 
report. There were no indications for holding this medication pre-
operatively, and, given the beneficial effect of mexiletine in PC, doing 
so may not have been in the patient’s best interest. It is therefore 
unknown, however, whether paralysis with the non- depolarizing agent 
rocuronium, as described in this report, would have been successful 
without the patient’s prior prescription of mexiletine. Therefore, 
additional research is needed to examine anesthetic management with 
rocuronium in patients with PC who are not taking mexiletine. 
Additional areas of focus may also include whether starting mexiletine 
in the pre-operative period (i.e., one month prior to surgery) in patients 
with PC shows benefit in reducing intra-operative complications for 
patients undergoing elective procedures. 
 
In conclusion, our report describes successful anesthetic management 
using non-depolarizing muscle relaxant, rocuronium, bolus propofol, 
ketamine, and continuous IV propofol with nitrous oxide in a patient 
with PC. This provides a potential management plan that may be 
applied to PC patients undergoing a variety of surgical procedures and 
eliminates risk associated with succinylcholine and possibly volatile 
anesthetics. Additionally, the use of rocuronium as a muscle relaxant 
may allow easier and more efficient intubations in these patients, 
reducing the risk associated with prolonged hypoxia that is occasionally 
observed in difficult intubations. Further research is needed to 
determine whether this approach is superior to previously reported 
techniques and should also aim to identify which agents may be 
effectively utilized to reverse a myotonic episode in PC patients if it 
occurs intra-operatively. 
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Succinylcholine depolarizes 
skeletal muscle membranes to 
induce paralysis and allow 
intubation for general 
anesthesia
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and subsequent electrolyte 
imbalance intra-operatively 
